Primary Systemic Amyloidosis - Pipeline Review, H2 2012 New Report
Primary Systemic Amyloidosis - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Primary Systemic Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Primary Systemic Amyloidosis. Primary Systemic Amyloidosis - Pipeline Review, Half Year is built using data and information sourced from databases, Company/University websites, SEC filings, investor presentations and featured press...
View full press release